19/02/2026 - Institutional news
The Hospital del Mar Research Institute (HMRIB) has appointed Judit Cubedo Ràfols as the new Managing Director of the institution. She took up the position on February 16. Judit Cubedo holds a PhD in Molecular and Cellular Biology and has a solid professional background combining scientific experience, strategic management, and health innovation. Throughout her career, she has held senior executive roles in biomedical organizations, leading institutional strategies, financial management, national and international competitive funding acquisition, technology transfer, and public-private partnerships.
Més informació "Judit Cubedo, new Managing Director of the Hospital del Mar Research Institute"
18/02/2026 - Press release
A European macro-study, published in The Lancet Regional Health-Europe, analyzes disease trajectories, associated conditions, and survival among people with cancer. Hospital del Mar and the Hospital del Mar Research Institute took part in the research, which evaluates real-world clinical data from a cohort of more than 1.7 million patients from eight European countries. The most frequent cancers in Europe are breast, prostate, colorectal, and lung cancer. The highest survival rates a re seen in breast and prostate cancer, while pancreatic cancer has the poorest prognosis. Databases from Spain, Estonia, and Switzerland show the best survival rates.
Més informació "A large-scale study analyzes the evolution of the most common cancers in Europe"
17/02/2026 - General information
The Spanish Association for Metastatic Breast Cancer (AECMM) has decided to grant one of the awards in the seventh edition of the M. Chiara Giorgetti Award for research into metastatic breast cancer to a project led by Dr. Toni Celià-Terrassa, a researcher in the Cancer Stem Cells and Metastasis Dynamics Research Group at the Hospital del Mar Research Institute. The project has received the second prize, endowed with €80,000. The award ceremony will take place next June. The project will build on the findings of a recent study by the same research group, published in the journal Cancer Cell. It will analyze the role of the protein TIM-3 in the development of resistance to neoadjuvant chemotherapy and how residual disease may serve as a predictor of metastasis. The expected results are intended to pave the way for the launch of a clinical trial led by the Medical Oncology Department at Hospital del Mar.
11/02/2026 - Institutional news
On 6 February, the XV Winter Olympic Games officially began. This year, the Games are being held in Milan-Cortina, Italy. This is a top-level sporting event that brings together athletes from around the world and mobilises numerous professionals across different fields, including anti-doping control. In this context, four professionals from the Catalonia Anti-Doping Laboratory - Rosa Ventura, Rosalia Ramírez, Deamelys Hernández and Manfred Conjeaud - will travel to Rome to join the Olympic laboratory team responsible for doping controls during the competition. Rosa Ventura will join the management and supervision group overseeing analytical activities, while Rosalia Ramírez, Deamelys Hernández and Manfred Conjeaud will work in the detection of anabolic steroids, one of the key analytical areas in sports anti-doping control.
11/02/2026 - General information
Today, 11 February, the Hospital del Mar Research Institute joins the celebration of the International Day of Women and Girls in Science, a key date to recognize the fundamental role of women in research and to continue moving towards a more just, diverse, and inclusive science. Despite the progress made, women remain underrepresented in science worldwide: less than one third of all researchers are women. At the Hospital del Mar Research Institute, every day we help advance science, medicine, and health. We are professionals from many different fields who research, care, create, and transform to expand knowledge and improve people's lives.
Més informació "The future of science begins with today's girls"
09/02/2026 - General information
The use of a standardized protocol significantly reduces headache after lumbar puncture, one of the most common side effects of this procedure, based on the analysis of more than 1,100 punctures. Improving the tolerability of lumbar puncture is key to advancing research in the preclinical stages of Alzheimer's disease and has been made possible thanks to the commitment of volunteers from the ALFA cohort. The study, published in Nature Scientific Reports, involved 724 cognitively healthy adults from the longitudinal ALFA cohort at the BBRC, with the support of the "la Caixa" Foundation.
05/02/2026 - Press release
A recent study from the Hospital del Mar Research Institute shows that cannabis use is associated with increased brain inflammation, which may affect the therapeutic effectiveness of antipsychotic treatments. The study analysed brain MRI scans from nearly 100 individuals-patients with first-episode psychosis and healthy volunteers-using a novel technique that measures extracellular free water. This is the first study to apply this method to examine the effects of cannabis use in psychosis. The findings are published in Molecular Psychiatry and reinforce recommendations against cannabis use in people with psychotic disorders.
Més informació "Cannabis use may influence treatment mechanisms in first-episode psychosis"
05/02/2026 - Press release
Infections caused by Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii are identified as priorities for clinical research. The study, published in the Journal of Infection and Public Health, involved 60 experts who reached consensus on the main priorities for the development of new clinical trials. The work carried out within the MePRAM project of CIBER has resulted in several priority lists-microorganisms, clinical syndromes, patient populations and anti-infective treatments-aimed at guiding future research from a personalised medicine approach.
Més informació "The roadmap for clinical research against antibiotic resistance established"
03/02/2026 - Press release
A research team from the Parc Taulí Research and Innovation Institute (I3PT), in collaboration with the Pere Virgili Health Research Institute (IISPV) and the Hospital del Mar Research Institute (HMRIB), has identified a clear association between the accumulation of abdominal fat and premature vascular aging in people with type 1 diabetes who have no previous history of cardiovascular disease. The research was based on a cohort of 179 individuals with this condition, all of whom were assessed at Parc Taulí University Hospital. Despite having good control of blood glucose levels, blood pressure, and lipid profile, approximately 10% of the individuals studied showed signs of premature vascular aging-a key factor in the development of cardiovascular and microvascular complications that directly affect quality of life and life expectancy.
Més informació "Abdominal fat is associated with premature vascular aging in type 1 diabetes"
02/02/2026 - Institutional news
The Hospital del Mar Research Institute Barcelona (HMRIB) hosted last Wednesday the 28th the inaugural session of the MAR Tech Transfer Academy, a new training programme designed to bring biomedical research closer to the market and to strengthen knowledge transfer and valorisation capabilities. The programme will count with three pillars: experience through a series of interactive sessions, curated tools that will be offered to the researchers and clinicians to help them during the transfer process and expert accompaniment, trough valorisation services.
Servei de Comunicació:
Marta Calsina(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
